China's Sinopharm COVID-19 vaccine approved for marketing in Tunisia
TUNIS, July 12 (Xinhua) -- Tunisian Ministry of Health announced on Monday that China's Sinopharm COVID-19 vaccine has been officially approved for marketing in Tunisia.
"The Ministry of Health has granted an exceptional and provisional marketing authorization in the Tunisian market for China's Sinopharm COVID-19 vaccine," said a ministry statement.
"The marketing authorization was granted after the issue was evaluated by the specialized committee in the field of virology, toxicology and the Technical Committee for Pharmaceutical Specialties," it added.
Since the start of the national vaccination campaign against the coronavirus on March 13, a total of 2,156,240 people have received the vaccines, with 631,083 taking two doses, according to the latest figures published by the ministry.
Photos
Related Stories
- UK gov't confirms lifting of most COVID restrictions next week despite surging cases
- COVID-19 Delta variant spreading worldwide "at scorching pace": WHO chief
- New batch of Sinovac COVID-19 vaccines in bulk arrives in Indonesia
- Kyrgyzstan receives 2nd batch of Chinese vaccines
- Chinese mainland reports nine new locally transmitted COVID-19 cases
Copyright © 2021 People's Daily Online. All Rights Reserved.